Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
A Move Aimed at Enriching the Existing CNS Portfolio and Enhancing Strategic Synergy across International Markets
HONG KONG, May 28, 2018 -- (Healthcare Sales & Marketing Network) -- Luye Pharma Group recently announced their acquisition of AstraZeneca... Biopharmaceuticals, Neurology, Acquisitions Luye Pharma, AstraZeneca, Seroquel, quetiapine, antipsychotic, antidepressant
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: AstraZeneca | Brain | Hong Kong Health | Marketing | Mergers and Aquisitions | Neurology | Pharmaceuticals | Seroquel